During the past decade, Emory Executive Park conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Emory Executive Park" are "Major Depressive Disorder" (1 trials), "Surgical Wound" (1 trials) and "Upper Extremity Injury" (1 trials). Many other conditions were trialed in "Emory Executive Park" in a lesser frequency.

Most popular intervention types in "Emory Executive Park" are "Behavioral" (1 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Behavioral Activation" (1 trials), "Fluoxetine" (1 trials), "Gut (FDA Approved) not buried interrupted" (1 trials), "Monocryl (FDA Approved) buried running" (1 trials) and "Monocryl buried interrupted" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emory Executive Park" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Emory Executive Park". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Emory Executive Park, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Emory Executive Park, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".